ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 163 filers reported holding ADMA BIOLOGICS INC in Q1 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,580 | -3.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2023 | $3,690 | +11.5% | 1,000 | 0.0% | 0.00% | – |
Q1 2023 | $3,310 | -14.7% | 1,000 | 0.0% | 0.00% | – |
Q4 2022 | $3,880 | +94.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2022 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2022 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2022 | $2,000 | +100.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2021 | $1,000 | -80.0% | 1,000 | -75.0% | 0.00% | – |
Q3 2021 | $5,000 | -16.7% | 4,000 | 0.0% | 0.00% | – |
Q2 2021 | $6,000 | -100.0% | 4,000 | -50.0% | 0.00% | – |
Q1 2021 | $14,080,000 | +175900.0% | 8,000 | +100.0% | 0.00% | – |
Q4 2020 | $8,000 | -20.0% | 4,000 | 0.0% | 0.00% | – |
Q3 2020 | $10,000 | +233.3% | 4,000 | +300.0% | 0.00% | – |
Q2 2020 | $3,000 | +50.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2020 | $2,000 | -50.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2019 | $4,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2019 | $4,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
Q2 2019 | $3,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |